Literature DB >> 12644073

Tacrolimus-induced hemolytic uremic syndrome case presentation in a lung transplant recipient.

D Shitrit1, D Starobin, D Aravot, G Fink, G Izbicki, M Kramer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12644073     DOI： 10.1016/s0041-1345(03)00015-0

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  3 in total

1.  Cyclosporin A impairs the secretion and activity of ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type 1 repeat).

Authors:  Klilah Hershko; Vijaya L Simhadri; Adam Blaisdell; Ryan C Hunt; Jordan Newell; Sandra C Tseng; Alon Y Hershko; Jae Won Choi; Zuben E Sauna; Andrew Wu; Richard J Bram; Anton A Komar; Chava Kimchi-Sarfaty
Journal:  J Biol Chem       Date:  2012-11-09       Impact factor: 5.157

2.  Basiliximab for early perioperative transplant-associated thrombotic microangiopathy after lung transplantation: a case report.

Authors:  Naohiro Ijiri; Masaaki Sato; Chihiro Konoeda; Kazuhiro Nagayama; Jun Nakajima
Journal:  Surg Case Rep       Date:  2022-09-29

3.  Dangerous drug interactions leading to hemolytic uremic syndrome following lung transplantation.

Authors:  Haralabos Parissis; Kate Gould; John Dark
Journal:  J Cardiothorac Surg       Date:  2010-09-02       Impact factor: 1.637
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.